Management

This page includes content on healthcare management, including health system, hospital, department and clinic business management and administration. Areas of focus are on cardiology and radiology department business administration. Subcategories covered in this section include healthcare economics, reimbursement, leadership, mergers and acquisitions, policy and regulations, practice management, quality, staffing, and supply chain.

Feature: Colorado HIE leader dishes on White House meeting, future plans

Gregory C. Reicks, DO, president of the Mesa County Physicians IPA, chairman of the regional health information exchange (HIE), Quality Health Network and family physician for 24 years, recently attended a White House/Department of Health and Human Services town hall meeting, representing the Colorado Beacon community. Reicks spoke with CMIO about the meeting and his Beacon experience.

Q&A: William Bria, MD, talks past, present & future role of the CMIO

The Association of Medical Directors of Information Systems (AMDIS) released the results of its annual CMIO survey on June 28 at the Physician-Computer Connection Symposium in Ojai, Calif. Moving beyond the numbers, William F. Bria, MD, chairman of the AMDIS board and director of informatics at Shriners Hospital for Children in Tampa, Fla., shared his thoughts on the survey with CMIO.

Study: Automated quality measurement systems require refining

Despite the increasing prevalence of EHRs in healthcare settings, automated care quality measurement has yet to become a widespread reality because care guidelines are not always specified, data are not standardized and much of the information required for automation is contained in unstructured formats, according to a research report published in the June issue of the American Journal of Managed Care.

HIMSS Webinar: PPACA helps nationalize health IT standards

The Patient Protection and Affordable Care Act (PPACA) may not directly affect health IT professionals as much as legislation like the HITECH Act and HIPAA, but thats no reason to overlook how the landmark 2010 universal healthcare bill builds upon past efforts to continue health ITs proliferation.

JAMIA: Making EHR data extraction more exact is possible

The medical information contained within EHRs is undoubtedly valuable to many of healthcares stakeholders, but its presentation as unstructured text often makes locating necessary information difficult, according to a study published July 6 in the Journal of the American Medical Informatics Association. Using a novel method to detect named entities within EHRs, however, researchers demonstrated that constructing more effective information extraction systems is possible at low costs.

Another 89 ACOs join federal cost-sharing programs

Eighty-nine new accountable care organizations (ACOs) serving 1.2 million Medicare patients in 40 states and Washington, D.C. officially entered into agreements with the Centers for Medicare & Medicaid Services (CMS) as of July 1.

CMS proposes to increase PCP payments, to change EHR incentives

The Centers for Medicare & Medicaid Services (CMS) has issued a proposed rule that would update the Medicare Physician Fee Schedule for calendar year 2013, increasing payments to family physicians by approximately 7 percent and to other primary care providers (PCP) by 3 to 5 percent.

Vetting a Partnership: When to Consider a Merger or Acquisition

Health care reform has catalyzed providers—especially independent hospitals—to consider the business models and structures within which they will operate going forward. As such, many will contemplate mergers or acquisitions, but there is much to consider before pursuing such a path.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.